Cannabix Technologies Inc
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and… Read more
Cannabix Technologies Inc (BLOZF) - Total Assets
Latest total assets as of October 2025: $2.17 Million USD
Based on the latest financial reports, Cannabix Technologies Inc (BLOZF) holds total assets worth $2.17 Million USD as of October 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cannabix Technologies Inc - Total Assets Trend (2012–2025)
This chart illustrates how Cannabix Technologies Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cannabix Technologies Inc - Asset Composition Analysis
Current Asset Composition (April 2025)
Cannabix Technologies Inc's total assets of $2.17 Million consist of 89.8% current assets and 10.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 76.8% |
| Accounts Receivable | $70.89K | 2.4% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Cannabix Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cannabix Technologies Inc's current assets represent 89.8% of total assets in 2025, an increase from 48.0% in 2012.
- Cash Position: Cash and equivalents constituted 76.8% of total assets in 2025, up from 36.6% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 2.4% of total assets.
Cannabix Technologies Inc Competitors by Total Assets
Key competitors of Cannabix Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Cannabix Technologies Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Cannabix Technologies Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Cannabix Technologies Inc is currently not profitable relative to its asset base.
Cannabix Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.42 | 15.67 | 79.42 |
| Quick Ratio | 6.38 | 15.67 | 79.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.65 Million | $ 3.22 Million | $ 7.28 Million |
Cannabix Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Cannabix Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 34.94 |
| Latest Market Cap to Assets Ratio | 15.77 |
| Asset Growth Rate (YoY) | -36.2% |
| Total Assets | $3.00 Million |
| Market Capitalization | $47.28 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Cannabix Technologies Inc's assets at a significant premium ( 15.77x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Cannabix Technologies Inc's assets decreased by 36.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cannabix Technologies Inc (2012–2025)
The table below shows the annual total assets of Cannabix Technologies Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-04-30 | $3.00 Million | -36.18% |
| 2024-04-30 | $4.70 Million | -32.35% |
| 2023-04-30 | $6.95 Million | -20.70% |
| 2022-04-30 | $8.76 Million | -15.62% |
| 2021-04-30 | $10.38 Million | +18.83% |
| 2020-04-30 | $8.74 Million | -39.99% |
| 2019-04-30 | $14.56 Million | -3.62% |
| 2018-04-30 | $15.10 Million | +98.82% |
| 2017-04-30 | $7.60 Million | +18.30% |
| 2016-04-30 | $6.42 Million | +27.16% |
| 2015-04-30 | $5.05 Million | +1546.08% |
| 2014-04-30 | $306.79K | +241.06% |
| 2013-04-30 | $89.95K | -6.47% |
| 2012-04-30 | $96.17K | -- |